Improvement estradiol beta-D-glucuronide cholestasis intravenous administration dimethylethanolamine rat intravenous administration dimethylethanolamine rat selective enrichment liver membranes polyunsaturated phosphatidylcholines effect dimethylethanolamine pretreatment cholestasis estradiol beta-D-glucuronide potent cholestatic agent study Dimethylethanolamine sodium-taurocholate mg/kg/min hr group control rats estradiol beta-D-glucuronide controls bile salt estradiol beta-D-glucuronide bolus mg/kg dimethylethanolamine-pretreated estradiol beta-D-control rats effect bile flow biliary lipid secretion hr estradiol beta-D-glucuronide inhibitory effect bile flow biliary lipid secretion dimethylethanolamine pretreatment maximum inhibition bile flow min estradiol beta-D-glucuronide administration gm basal gm estradiol beta-D-glucuronide controls whereas dimethylethanolamine-pretreated rats basal gm Bile flow biliary secretion cholesterol phosphatidylcholine bile salts dimethylethanolamine-pretreated rats estradiol beta-D-glucuronide controls cholestatic phase inhibitory effect beta-D-glucuronide bile flow marked decrease membrane fluidity fluorescence anisotropy cholesterol enrichment microsomes sinusoidal canalicular liver plasma membranes inhibition sinusoidal Na+ -ATPase activity membrane alterations min estradiol beta-D-glucuronide administration complete normalization bile flow Dimethylethanolamine pretreatment reduction membrane fluidity cholesterol enrichment inhibition Na+ -ATPase estradiol beta-D-glucuronide administration membrane subfractions min administration addition dimethylethanolamine-pretreated rats polyunsaturated fatty acids membrane phosphatidylcholine respect control groups Dilatation canaliculi loss microvilli evident estradiol beta-D-glucuronide controls min estradiol beta-D-glucuronide administration ABSTRACT TRUNCATED AT WORDS 